Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2021
Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on MortalityAlicia M Hinze, Jamie Perin, Adrianne Woods, et al.
Pain|February 13, 2002
The impact of pain and symptoms of depression in sclerodermaLisa M Benrud-Larson, Jennifer A Haythornthwaite, Leslie J Heinberg, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|April 10, 2003
Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial functionLisa M Benrud-Larson, Leslie J Heinberg, Christy Boling, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated SclerodermaAmi A Shah, George Xu, Antony Rosen, et al.
Arthritis Care & Research|January 26, 2012
Efficacy of Rho kinase inhibitor fasudil in secondary Raynaud's phenomenonAndrea Fava, Peter K Wung, Fredrick M Wigley, et al.
The Journal of Rheumatology|December 5, 2002
Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activationRichard F Macko, Allan C Gelber, Bradford A Young, et al.
Arthritis Care & Research|August 9, 2021
Slow Colonic Transit in Systemic Sclerosis: An Objective Assessment of Risk Factors and Clinical PhenotypeJenice X Cheah, Jamie Perin, Elizabeth R Volkmann, et al.
Rheumatology (Oxford, England)|December 5, 2022
Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosisCarrie Richardson, Jamie Perin, Scott Zeger, et al.
Arthritis and Rheumatism|January 31, 2009
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung diseaseStephen C Mathai, Laura K Hummers, Hunter C Champion, et al.
Annals of the Rheumatic Diseases|April 22, 2018
Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancerTakeru Igusa, Laura K Hummers, Kala Visvanathan, et al.
Pageof 16